Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Spherics
Spherics focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles.
Spherics
Mansfield, MA
